Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 3, 6, 12, & 24 months
Awards & highlights
Study Summary
Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.
Eligible Conditions
- Discogenic Pain
- Lower Back Pain
- Back Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1, 3, 6, 12, & 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 3, 6, 12, & 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Numeric Pain Rating Scale (NPRS)
Oswestry Disability Index (ODI)
Pain Medication
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: VIA Disc NPExperimental Treatment1 Intervention
Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment
Find a Location
Who is running the clinical trial?
Moxie ClinicalUNKNOWN
VIVEX Biologics, Inc.Lead Sponsor
7 Previous Clinical Trials
10,306 Total Patients Enrolled
1 Trials studying Discogenic Pain
10,000 Patients Enrolled for Discogenic Pain
Jasmine WilsonStudy Directorcro
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger